Recruiting NCT07281534

Test-Retest Reliability of Cardiopulmonary Exercise Testing With Echocardiography

No phase Interventional Dyspnea; Cardiac

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: The protocol lists: CPETecho.
Who it may be relevant to: Registry conditions: Dyspnea; Cardiac. Basic parameters: No limits · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: Belgium
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Analysing the Test-Retest Reliability of Cardiopulmonary Exercise Testing With Echocardiography

Overview

CPETecho is progressively employed in diagnostic settings for pathophysiological detection, offering comprehensive assessment of both pulmonary and cardiac functions. This technique evolves from its invasive counterpart, where a diagnostic catheter is employed for hemodynamic monitoring, by substituting the invasive component with non-invasive echocardiography. Nevertheless, data on the test-retest reliability of CPETecho remain sparse, a factor critical in differentiating between measurement effects and actual therapeutic impacts.

Interventions

Diagnostic test CPETecho
repeat CPETecho with a one-week interval

Primary outcome measures

Correlation coefficient (ICC) [Time frame: Up to 2 weeks]

Eligibility criteria

Inclusion criteria

Capable of performing a maximal exercise test.
Provide signed and dated informed consent.

Exclusion criteria

\- Unstable symptoms, whereby therapy cannot be delayed for a week.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation: N/A
Model: Single group
Masking: Open label
Primary purpose: Diagnostic

Study locations

Belgium · 1 center

Ziekenhuis Oost-Limburg — Genk

Identifiers

NCT: NCT07281534 · Z-2024011

Primary sources (government registries)

ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗